查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573083

Butorphanol市场：按产品类型、应用和分销管道划分 - 全球预测 2025-2030

Butorphanol Market by Product Type (Injection, Nasal Spray), Application (Cancer Pain, Labor Pain, Migraine Pain), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Butorphanol市值为2.7147亿美元，预计2024年将达到2.8374亿美元，复合年增长率为4.30%，预计到2030年将达到3.6475亿美元。

Butorphanol是一种用于疼痛管理的鸦片类镇痛药，在医疗保健环境中具有多种用途，包括缓解分娩和手术期间的疼痛，以及控制对其他鸦片类镇痛药有抵抗力的患者的疼痛。对Butorphanol的需求在于其在治疗中度至重度疼痛方面的有效性，特别是在替代药物无效或不合适的情况下。其应用范围扩展到医院、手术中心和兽医等最终用户。市场范围包括製药、医疗机构、兽医医院等，需要稳定的供应以满足多样化的疼痛管理需求。

主要市场统计
基准年[2023] 27147万美元
预测年份 [2024] 2.8374亿美元
预测年份 [2030] 36475万美元
复合年增长率（%） 4.30%

目前的市场分析强调，慢性疼痛和手术相关手术的日益普及是关键的成长要素，推动了对Butorphanol等有效止痛药的需求不断增长。此外，医疗保健提供者对疼痛管理方案的认识不断提高也推动了市场的扩张。透过扩大Butorphanol的兽医应用，专注于牲畜和宠物，并将其引入缺乏强大疼痛管理解决方案的新兴市场，存在潜在的机会。与医疗机构和动物用药品公司的策略联盟和伙伴关係可以进一步扩大市场占有率。

然而，市场面临限制和挑战，特别是在阿片类药物相关法规以及成瘾和滥用风险方面，这可能会阻碍成长。阿片类药物的负面形象需要严格遵守监管指南，并可能影响市场渗透率。此外，替代性非鸦片类止痛药的出现可能会减少对Butorphanol的需求。

创新需要开发成瘾性较低的配方，并研究和开发优化功效和安全性的输送系统。此外，强调其独特的药理学方面可能会带来进步，并有可能在更广泛的鸦片类药物市场中开闢一席之地。总体而言，市场竞争仍然激烈，但前景广阔，在不同的应用和地区都有成长空间，这表明将重点放在创新和战略市场定位，以充分利用Butorphanol带来的机会。

市场动态：揭示快速发展的Butorphanol市场的关键市场洞察

供需的动态交互作用正在改变Butorphanol市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 影响Butorphanol供应链物流的严格监管政策和指南
    • 扩大Butorphanol在动物用药品和动物保健品市场的应用
    • 製药公司与研究机构合作开发新药
    • 医疗费用上涨，加大疼痛管理研发投入
  • 市场限制因素
    • 由于替代性疼痛管理疗法的市场竞争，Butorphanol的市场占有率可能会下降
    • Butorphanol诺合成和製造流程的高成本推高了整体市场定价
  • 市场机会
    • 探索已开发地区对Butorphanol作为疼痛管理解决方案不断增长的需求
    • Butorphanol作为动物镇痛药在兽医领域的发展潜力分析
    • 随着医疗保健机会的增加，调查Butorphanol在新兴国家的市场扩张机会
  • 市场挑战
    • 严格的监管核准和高成本限制影响Butorphanol市场扩张
    • 新兴市场对Butorphanol作为疼痛管理解决方案的认识和采用率较低

波特的五力：驾驭Butorphanol市场的策略工具

波特的五力架构是了解Butorphanol市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解Butorphanol市场的外部影响

外部宏观环境因素在塑造Butorphanol市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解Butorphanol市场的竞争格局

Butorphanol市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵Butorphanol市场供应商的绩效评估

FPNV定位矩阵是评估Butorphanol市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了Butorphanol市场的成功之路

Butorphanol市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 影响Butorphanol供应链物流的严格监管政策和指南
      • 扩大Butorphanol在兽医和动物保健市场的应用
      • 製药公司与研究机构合作开发先进药物
      • 增加医疗支出和疼痛管理研发投资
    • 抑制因素
      • 替代疼痛管理疗法的市场竞争可能会减少Butorphanol的市场占有率
      • Butorphanol诺合成和製造流程的高成本导致整个市场的价格上涨
    • 机会
      • 调查已开发地区对Butorphanol作为疼痛管理解决方案不断增长的需求
      • 分析Butorphanol在兽医药物中缓解动物疼痛的成长潜力
      • 随着医疗保健的普及，调查Butorphanol在新兴国家的市场扩张机会
    • 任务
      • 严格的监管核准和高成本限制影响Butorphanol市场扩张
      • 新兴市场对Butorphanol作为疼痛管理解决方案的认识和采用有限
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章Butorphanol市场：依产品类型

  • 注射
  • 鼻喷剂

第七章Butorphanol市场：依应用分类

  • 癌症痛
  • 阵痛
  • 偏头痛
  • 术后疼痛

第八章Butorphanol市场：依通路分类

  • 离线
  • 在线的

第九章 美洲Butorphanol市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太布托Butorphanol市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲Butorphanol市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0322

The Butorphanol Market was valued at USD 271.47 million in 2023, expected to reach USD 283.74 million in 2024, and is projected to grow at a CAGR of 4.30%, to USD 364.75 million by 2030.

Butorphanol is an opioid analgesic used for pain management, encompassing a variety of applications in healthcare settings, such as pain relief during labor or surgery and controlling pain in patients resistant to other opioid analgesics. The necessity of Butorphanol lies in its efficacy in managing moderate to severe pain, particularly in scenarios where alternatives may not be effective or suitable. Its application extends to end-users in hospitals, surgical centers, and veterinary medicine. The market scope includes pharmaceuticals, healthcare institutions, and veterinary practices, demanding consistent supply to address diverse pain management needs.

KEY MARKET STATISTICS
Base Year [2023] USD 271.47 million
Estimated Year [2024] USD 283.74 million
Forecast Year [2030] USD 364.75 million
CAGR (%) 4.30%

Current market insights emphasize the increasing prevalence of chronic pain conditions and surgery-related procedures as key growth influencers, driving heightened demand for effective analgesics like Butorphanol. Additionally, rising awareness regarding pain management options among healthcare providers bolsters market expansion. Potential opportunities lie in expanding the veterinary application of Butorphanol, focusing on livestock and pets, and introducing it into emerging markets lacking robust pain management solutions. Strategic collaborations and partnerships with healthcare institutions and veterinary pharmaceutical companies can further augment market presence.

However, the market faces limitations and challenges, especially concerning opioid-related regulations and the risk of addiction and misuse, which can hinder growth. The negative perception surrounding opioids necessitates stringent compliance with regulatory guidelines, possibly affecting market penetration. Furthermore, the advent of alternative non-opioid pain relievers may dampen Butorphanol's demand.

For innovation, research could focus on developing Butorphanol formulations with reduced addictive properties or delivery systems optimizing its efficacy and safety profile. Emphasizing its unique pharmacological aspects may also yield advancements, potentially carving out a niche within the broader opioid market. Overall, the market remains competitive but promising, with scope for growth in diversified applications and regions, suggesting a focus on innovation and strategic market positioning to fully leverage the opportunities Butorphanol presents.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Butorphanol Market

The Butorphanol Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Stringent regulatory policies and guidelines affecting the Butorphanol supply chain logistics
    • Expanding applications of Butorphanol in veterinary medicine and animal healthcare markets
    • Collaborative efforts between pharmaceutical companies and research institutions for advanced drug development
    • Increasing healthcare expenditure and investment in pain management research and development
  • Market Restraints
    • Market competition from alternative pain management therapies may erode butorphanol's market share
    • High cost of butorphanol synthesis and production processes increases overall market pricing
  • Market Opportunities
    • Exploring the rise in demand for Butorphanol as a pain management solution in developed regions
    • Analyzing the growth potential of Butorphanol in veterinary medicine for animal pain relief
    • Investigating the market expansion opportunities for Butorphanol in emerging countries with increasing healthcare access
  • Market Challenges
    • Stringent regulatory approvals and high-cost constraints affecting butorphanol market expansion
    • Limited awareness and adoption of butorphanol as a pain management solution in emerging markets

Porter's Five Forces: A Strategic Tool for Navigating the Butorphanol Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Butorphanol Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Butorphanol Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Butorphanol Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Butorphanol Market

A detailed market share analysis in the Butorphanol Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Butorphanol Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Butorphanol Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Butorphanol Market

A strategic analysis of the Butorphanol Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Butorphanol Market, highlighting leading vendors and their innovative profiles. These include Akorn, Inc., Amneal Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., BioDelivery Sciences International, Inc., Egalet Corporation, Endo Pharmaceuticals Inc., Esteve Pharmaceuticals, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals PLC, Hospira, Inc., Johnson & Johnson, Lupin Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Mylan N.V., Novartis International AG, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Butorphanol Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Injection and Nasal Spray.
  • Based on Application, market is studied across Cancer Pain, Labor Pain, Migraine Pain, and Postoperative Pain.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Stringent regulatory policies and guidelines affecting the Butorphanol supply chain logistics
      • 5.1.1.2. Expanding applications of Butorphanol in veterinary medicine and animal healthcare markets
      • 5.1.1.3. Collaborative efforts between pharmaceutical companies and research institutions for advanced drug development
      • 5.1.1.4. Increasing healthcare expenditure and investment in pain management research and development
    • 5.1.2. Restraints
      • 5.1.2.1. Market competition from alternative pain management therapies may erode butorphanol's market share
      • 5.1.2.2. High cost of butorphanol synthesis and production processes increases overall market pricing
    • 5.1.3. Opportunities
      • 5.1.3.1. Exploring the rise in demand for Butorphanol as a pain management solution in developed regions
      • 5.1.3.2. Analyzing the growth potential of Butorphanol in veterinary medicine for animal pain relief
      • 5.1.3.3. Investigating the market expansion opportunities for Butorphanol in emerging countries with increasing healthcare access
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approvals and high-cost constraints affecting butorphanol market expansion
      • 5.1.4.2. Limited awareness and adoption of butorphanol as a pain management solution in emerging markets
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Butorphanol Market, by Product Type

  • 6.1. Introduction
  • 6.2. Injection
  • 6.3. Nasal Spray

7. Butorphanol Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer Pain
  • 7.3. Labor Pain
  • 7.4. Migraine Pain
  • 7.5. Postoperative Pain

8. Butorphanol Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Americas Butorphanol Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Butorphanol Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Butorphanol Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akorn, Inc.
  • 2. Amneal Pharmaceuticals, Inc.
  • 3. Aurobindo Pharma USA, Inc.
  • 4. BioDelivery Sciences International, Inc.
  • 5. Egalet Corporation
  • 6. Endo Pharmaceuticals Inc.
  • 7. Esteve Pharmaceuticals
  • 8. Fresenius Kabi USA, LLC
  • 9. Hikma Pharmaceuticals PLC
  • 10. Hospira, Inc.
  • 11. Johnson & Johnson
  • 12. Lupin Pharmaceuticals, Inc.
  • 13. Mallinckrodt Pharmaceuticals
  • 14. Mylan N.V.
  • 15. Novartis International AG
  • 16. Pfizer Inc.
  • 17. Purdue Pharma L.P.
  • 18. Sanofi S.A.
  • 19. Sun Pharmaceutical Industries Ltd.
  • 20. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. BUTORPHANOL MARKET RESEARCH PROCESS
  • FIGURE 2. BUTORPHANOL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BUTORPHANOL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BUTORPHANOL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BUTORPHANOL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BUTORPHANOL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BUTORPHANOL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BUTORPHANOL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BUTORPHANOL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BUTORPHANOL MARKET DYNAMICS
  • TABLE 7. GLOBAL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BUTORPHANOL MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BUTORPHANOL MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BUTORPHANOL MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BUTORPHANOL MARKET SIZE, BY LABOR PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BUTORPHANOL MARKET SIZE, BY MIGRAINE PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BUTORPHANOL MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BUTORPHANOL MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BUTORPHANOL MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. BUTORPHANOL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BUTORPHANOL MARKET, FPNV POSITIONING MATRIX, 2023